Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China

RecruitingOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2027

Conditions
Interstitial Lung Disease (ILD)
Trial Locations (1)

100029

RECRUITING

China-Japan Friendship Hospital, Beijing

All Listed Sponsors
collaborator

The First Affiliated Hospital of Guangzhou Medical University

OTHER

collaborator

Nankai University

OTHER

collaborator

Jilin University

OTHER

collaborator

Shanghai Pulmonary Hospital, Shanghai, China

OTHER

collaborator

Shanghai Chest Hospital

OTHER

collaborator

Institute of Basic Medical Sciences CAMS

UNKNOWN

collaborator

Tongji Hospital

OTHER

collaborator

National Institute for Occupational Health and Poison Control

UNKNOWN

collaborator

Infervision Medical Technology Company Limited

UNKNOWN

lead

Dai Huaping

OTHER